Gene: TCEANC
Official Full Name: transcription elongation factor A N-terminal and central domain containingprovided by HGNC
Gene Summary: Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13514 | TCEANC Knockout cell line (HEK293) | Human | TCEANC | 1:3~1:6 | Negative | Online Inquiry |
KO13515 | TCEANC Knockout cell line (A549) | Human | TCEANC | 1:3~1:4 | Negative | Online Inquiry |
TCEANC Gene Knockout Cell Lines are precisely engineered cellular models designed to facilitate the study of gene function and regulation through the targeted deletion of specific genes. Utilizing advanced CRISPR-Cas9 technology, these cell lines restore or eliminate genetic material, allowing researchers to observe the resulting phenotypic changes and assess gene activity in a controlled environment. By systematically inactivating genes of interest, TCEANC cell lines enable scientists to unravel complex biological pathways, offering insights into cellular mechanisms underlying diseases.
The primary mechanism of TCEANC Gene Knockout Cell Lines relies on the robust CRISPR-Cas9 system, which introduces double-strand breaks in DNA at predetermined locations. This results in the disruption of gene coding sequences, effectively knocking out gene expression and creating models that mimic genetic disorders or pathways linked to disease. This manipulation provides invaluable research tools for functional genomics, drug discovery, and therapeutic development.
The scientific importance of these cell lines cannot be overstated, as they play a pivotal role in biomedical research, drug development, and the exploration of gene therapy strategies. By utilizing TCEANC cell lines, researchers can conduct high-throughput screening assays, validate drug targets, and elucidate molecular mechanisms of action in unique cellular contexts, contributing to advancements in precision medicine.
One of the distinguishing advantages of TCEANC Gene Knockout Cell Lines is their extensive pre-validation for reliable and reproducible results. Unlike other knockout models, which may introduce unintended mutations or exhibit inconsistent expression levels, TCEANC lines are vetted through multiple validation assays. This quality assurance enhances their reliability for both academic and industrial applications.
For researchers and clinicians, TCEANC Gene Knockout Cell Lines are not just a product, but an essential resource that accelerates scientific discovery and innovation. Their versatility and precision allow users to generate rigorous data, ultimately contributing to breakthroughs in understanding diseases and developing effective therapies.
With a strong commitment to innovation and quality, our company specializes in providing high-performance biological products, including TCEANC Gene Knockout Cell Lines, designed to meet the evolving needs of researchers dedicated to advancing life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.